Back to results
US 2019/0314342 A1Published application
Method for treating demyelinating neuropathy with biotin
AssigneeMedday Pharmaceuticals
InventorFrédéric SEDEL
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of biotin for treating Amyotrophic Lateral Sclerosis, as well as demyelinating peripheral neuropathies and Neuromyelitis optica (NMO).
Claims21
1-20. (canceled)
A method for the treatment of a demyelinating neuropathy, comprising administering to a patient in need thereof a composition comprising an amount of biotin sufficient to treat said demyelinating neuropathy.
A composition comprising an amount of biotin sufficient to treat a demyelinating neuropathy.
Dependencies are inferred from the claim text.